Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

PolandBack to Poland

Clinical trials in Świnoujście

2 clinical trials in Świnoujście, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Świnoujście at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Świnoujście

Open in trial search

Cardiac failure+1

Recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S

Cardiac failure

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Świnoujście

What the registry says about research in the country

01 Świnoujście
Cardiovascular Diseases
Clinical research in Świnoujście is focused on cardiovascular diseases, with studies centered on heart failure and related high-risk conditions. The trials are designed to assess whether new treatment approaches can improve outcomes for people living with complex forms of heart failure. Study of HFpEF and HFmrEF in people with obesity Research on heart failure with systemic inflammation Evaluation of new therapies aimed at reducing cardiovascular death and heart failure events These ongoing trials in Świnoujście are exploring whether adding novel treatments to standard care can better control disease progression and lower the risk of serious complications.
Heart Failure and Inflammation
One area of research examines heart failure in patients with HFmrEF or HFpEF alongside systemic inflammation. The main goal is to test a therapy that may help reduce worsening heart failure and improve clinical outcomes. Focus on heart failure with preserved or mildly reduced ejection fraction Investigation of the role of inflammation in disease burden Testing a potential treatment for better protection against CV events This research reflects a growing interest in more targeted approaches for patients whose heart failure may be linked to inflammatory pathways.
Heart Failure and Obesity
Another trial in the city looks at heart failure combined with obesity, especially in people with HFpEF or HFmrEF. It aims to evaluate whether a new therapy can help lower the chance of hospitalization and urgent medical visits. Study population includes HFpEF and HFmrEF Major disease factor: obesity Assessment of treatment effectiveness for reducing heart failure hospitalisation Focus on improving overall cardiovascular risk The research is aimed at finding better ways to manage this difficult combination of metabolic and cardiac disease.
Back to PolandAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.